Autoimmune gastritis: Pathologist's viewpoint

World Journal of Gastroenterology

Volumn 21, Issue 42, 2015, Pages 12179-12189

  Coati, Irene ^a   Fassan, Matteo ^a   Farinati, Fabio ^a   Graham, David Y ^b   Genta, Robert M ^c,d   Rugge, Massimo ^a  

^a UNIVERSITY OF PADOVA   (Italy)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

^c MIRACA LIFE SCIENCES   (United States)

^d UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

Autoimmune gastritis; Carcinoids; Metaplasia; Operative link for gastritis assessment staging

Indexed keywords

GASTRIN; INTRINSIC FACTOR; PARIETAL CELL ANTIBODY; PEPSINOGEN; BIOLOGICAL MARKER;

ADENOMA; ANTIBODY BLOOD LEVEL; AUTOIMMUNE DISEASE; AUTOIMMUNE GASTRITIS; AUTOIMMUNE HEPATITIS; CANCER RISK; CELL HYPERPLASIA; CLINICAL FEATURE; COMORBIDITY; DIABETES MELLITUS; ENTEROCHROMAFFIN LIKE CELL; GASTRIN BLOOD LEVEL; GASTRIN RELEASE; GASTRITIS; HISTOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; IRON ABSORPTION; IRON DEFICIENCY ANEMIA; LAMINA PROPRIA; MICROCYTIC ANEMIA; NEUROENDOCRINE TUMOR; PATHOLOGIST; PERNICIOUS ANEMIA; PHENOTYPE; PYLORIC GLAND ADENOMA; PYLORUS GLAND; REVIEW; SECONDARY PREVENTION; SEROLOGY; STOMACH ADENOCARCINOMA; STOMACH FUNDUS GLAND; STOMACH PH; T LYMPHOCYTE; AUTOIMMUNE DISEASES; AUTOIMMUNITY; BIOPSY; CHEMISTRY; IMMUNOLOGY; PATHOLOGY; PREDICTIVE VALUE; PROCEDURES; PROGNOSIS; STEM CELL; STOMACH;

AUTOIMMUNE DISEASES; AUTOIMMUNITY; BIOMARKERS; BIOPSY; GASTRITIS; HUMANS; IMMUNOHISTOCHEMISTRY; PATHOLOGY; PREDICTIVE VALUE OF TESTS; PROGNOSIS; STEM CELLS; STOMACH;

EID: 84947460429     PISSN: 10079327     EISSN: 22192840     Source Type: Journal    
DOI: 10.3748/wjg.v21.i42.12179     Document Type: Review

References (60)

1. Faber K. Gastritis and Its Consequences. JAMA 1935; 105: 2098 [DOI: 10.1001/jama.1935.02760510070032]
2. Bizzozero G. "Ueber die schlauchförmigen Drüsen des Magendarmkanals und die Beziehungen ihres Epitheles zu dem Oberflächenepithel der Schleimhaut". Archiv für mikroskopische Anatomie 1893; 42: 82-152 [DOI: 10.1007/BF02975307]
3. Vojdani A. A Potential Link between Environmental Triggers and Autoimmunity. Autoimmune Dis 2014; 2014: 437231 [PMID: 24688790 DOI: 10.1155/2014/437231]
4. Kamradt T, Göggel R, Erb KJ. Induction, exacerbation and inhibition of allergic and autoimmune diseases by infection. Trends Immunol 2005; 26: 260-267 [PMID: 15866239]
5. Kondrashova A, Seiskari T, Ilonen J, Knip M, Hyöty H. The 'Hygiene hypothesis' and the sharp gradient in the incidence of autoimmune and allergic diseases between Russian Karelia and Finland. APMIS 2013; 121: 478-493 [PMID: 23127244 DOI: 10.1111/apm.12023]
6. Neumann WL, Coss E, Rugge M, Genta RM. Autoimmune atrophic gastritis-pathogenesis, pathology and management. Nat Rev Gastroenterol Hepatol 2013; 10: 529-541 [PMID: 23774773 DOI: 10.1038/nrgastro.2013.101]
7. Baggett RT, Welsh JD. Observations on the effects of glucocorticoid administration in pernicious anemia. Am J Dig Dis 1970; 15: 871-881 [PMID: 5501352]
8. Rugge M, Fassan M, Pizzi M, Zorzetto V, Maddalo G, Realdon S, De Bernard M, Betterle C, Cappellesso R, Pennelli G, de Boni M, Farinati F. Autoimmune gastritis: histology phenotype and OLGA staging. Aliment Pharmacol Ther 2012; 35: 1460-1466 [PMID: 22519568 DOI: 10.1111/j.1365-2036.2012.05101.x]
9. Vannella L, Lahner E, Annibale B. Risk for gastric neoplasias in patients with chronic atrophic gastritis: a critical reappraisal. World J Gastroenterol 2012; 18: 1279-1285 [PMID: 22493541 DOI: 10.3748/wjg.v18.i12.1279]
10. Massironi S, Cavalcoli F, Rossi RE, Conte D, Spampatti MP, Ciafardini C, Verga U, Beck-Peccoz P, Peracchi M. Chronic autoimmune atrophic gastritis associated with primary hyperparathyroidism: a transversal prospective study. Eur J Endocrinol 2013; 168: 755-761 [PMID: 23447517 DOI: 10.1530/EJE-12-1067]
11. Carmel R. Prevalence of undiagnosed pernicious anemia in the elderly. Arch Intern Med 1996; 156: 1097-1100 [PMID: 8638997]
12. Rugge M, Correa P, Dixon MF, Fiocca R, Hattori T, Lechago J, Leandro G, Price AB, Sipponen P, Solcia E, Watanabe H, Genta RM. Gastric mucosal atrophy: interobserver consistency using new criteria for classification and grading. Aliment Pharmacol Ther 2002; 16: 1249-1259 [PMID: 12144574]
13. Miceli E, Lenti MV, Padula D, Luinetti O, Vattiato C, Monti CM, Di Stefano M, Corazza GR. Common features of patients with autoimmune atrophic gastritis. Clin Gastroenterol Hepatol 2012; 10: 812-814 [PMID: 22387252 DOI: 10.1016/j.cgh.2012.02.018]
14. Hershko C, Ronson A, Souroujon M, Maschler I, Heyd J, Patz J. Variable hematologic presentation of autoimmune gastritis: agerelated progression from iron deficiency to cobalamin depletion. Blood 2006; 107: 1673-1679 [PMID: 16239424]
15. Vannella L, Lahner E, Osborn J, Annibale B. Systematic review: gastric cancer incidence in pernicious anaemia. Aliment Pharmacol Ther 2013; 37: 375-382 [PMID: 23216458 DOI: 10.1111/apt.12177]
16. Dengue in the South Pacific. Wkly Epidemiol Rec 1990; 65: 255-256 [PMID: 2206927 DOI: 10.1002/dmrr.1267]
17. Amerio P, Tracanna M, De Remigis P, Betterle C, Vianale L, Marra ME, Di Rollo D, Capizzi R, Feliciani C, Tulli A. Vitiligo associated with other autoimmune diseases: polyglandular autoimmune syndrome types 3B+C and 4. Clin Exp Dermatol 2006; 31: 746-749 [PMID: 16803462]
18. Betterle C, Zanchetta R. Update on autoimmune polyendocrine syndromes (APS). Acta Biomed 2003; 74: 9-33 [PMID: 12817789]
19. Bogdanos DP, Smyk DS, Invernizzi P, Rigopoulou EI, Blank M, Pouria S, Shoenfeld Y. Infectome: a platform to trace infectious triggers of autoimmunity. Autoimmun Rev 2013; 12: 726-740 [PMID: 23266520 DOI: 10.1016/j.autrev.2012.12.005]
20. Toh BH. Diagnosis and classification of autoimmune gastritis. Autoimmun Rev 2014; 13: 459-462 [PMID: 24424193 DOI: 10.1016/j.autrev.2014.01.048]
21. Park JY, Lam-Himlin D, Vemulapalli R. Review of autoimmune metaplastic atrophic gastritis. Gastrointest Endosc 2013; 77: 284-292 [PMID: 23199649 DOI: 10.1016/j.gie.2012.09.033]
22. Bergman MP, Faller G, D'Elios MM, Del Prete G, Vandenbroucke-Grauls CMJE, Appelmelk BJ. Gastric automminity. In: Mobley HLT, Mendz GL, Hazell SL, editors. Helicobacter pylori: Physiology and Genetics. Washington DC: ASM Press, 2001: chapter 36 [PMID: 21290740]
23. Bergman MP, D'Elios MM. Cytotoxic T cells in H. pylori-related gastric autoimmunity and gastric lymphoma. J Biomed Biotechnol 2010; 2010: 104918 [PMID: 20617132 DOI: 10.1155/2010/104918]
24. DiPaolo RJ, Brinster C, Davidson TS, Andersson J, Glass D, Shevach EM. Autoantigen-specific TGFbeta-induced Foxp3+ regulatory T cells prevent autoimmunity by inhibiting dendritic cells from activating autoreactive T cells. J Immunol 2007; 179: 4685-4693 [PMID: 17878367]
25. Yamada T, Miwa H, Fujino T, Hirai S, Yokoyama T, Sato N. Improvement of gastric atrophy after Helicobacter pylori eradication therapy. J Clin Gastroenterol 2003; 36: 405-410 [PMID: 12702982]
26. Zhang Y, Weck MN, Schöttker B, Rothenbacher D, Brenner H. Gastric parietal cell antibodies, Helicobacter pylori infection, and chronic atrophic gastritis: evidence from a large population-based study in Germany. Cancer Epidemiol Biomarkers Prev 2013; 22: 821-826 [PMID: 23456556 DOI: 10.1158/1055-9965.EPI-12-1343]
27. Lombardo L, Leto R, Molinaro G, Migliardi M, Ravarino N, Rocca R, Torchio B. Prevalence of atrophic gastritis in dyspeptic patients in Piedmont. A survey using the GastroPanel test. Clin Chem Lab Med 2010; 48: 1327-1332 [PMID: 20604730 DOI: 10.1515/CCLM.2010.256]
28. Telaranta-Keerie A, Kara R, Paloheimo L, Härkönen M, Sipponen P. Prevalence of undiagnosed advanced atrophic corpus gastritis in Finland: an observational study among 4, 256 volunteers without specific complaints. Scand J Gastroenterol 2010; 45: 1036-1041 [PMID: 20446846 DOI: 10.3109/00365521.2010.487918]
29. McNicholl AG, Forné M, Barrio J, De la Coba C, González B, Rivera R, Esteve M, Fernandez-Bañares F, Madrigal B, Gras-Miralles B, Perez-Aisa A, Viver-Pi-Sunyer JM, Bory F, Rosinach M, Loras C, Esteban C, Santolaria S, Gomollon F, Valle J, Gisbert JP. Accuracy of GastroPanel for the diagnosis of atrophic gastritis. Eur J Gastroenterol Hepatol 2014; 26: 941-948 [PMID: 25014624 DOI: 10.1097/MEG.0000000000000132]
30. Strickland RG, Mackay IR. A reappraisal of the nature and significance of chronic atrophic gastritis. Am J Dig Dis 1973; 18: 426-440 [PMID: 4573514]
31. Torbenson M, Abraham SC, Boitnott J, Yardley JH, Wu TT. Autoimmune gastritis: distinct histological and immunohistochemical findings before complete loss of oxyntic glands. Mod Pathol 2002; 15: 102-109 [PMID: 11850538]
32. Weis VG, Goldenring JR. Current understanding of SPEM and its standing in the preneoplastic process. Gastric Cancer 2009; 12: 189-197 [PMID: 20047123 DOI: 10.1007/s10120-009-0527-6]
33. Li Q, Karam SM, Gordon JI. Diphtheria toxin-mediated ablation of parietal cells in the stomach of transgenic mice. J Biol Chem 1996; 271: 3671-3676 [PMID: 8631979]
34. Nam KT, Lee HJ, Sousa JF, Weis VG, O'Neal RL, Finke PE, Romero-Gallo J, Shi G, Mills JC, Peek RM, Konieczny SF, Goldenring JR. Mature chief cells are cryptic progenitors for metaplasia in the stomach. Gastroenterology 2010; 139: 2028-2037. e9 [PMID: 20854822 DOI: 10.1053/j.gastro.2010.09.005]
35. Sousa JF, Ham AJ, Whitwell C, Nam KT, Lee HJ, Yang HK, Kim WH, Zhang B, Li M, LaFleur B, Liebler DC, Goldenring JR. Proteomic profiling of paraffin-embedded samples identifies metaplasia-specific and early-stage gastric cancer biomarkers. Am J Pathol 2012; 181: 1560-1572 [PMID: 22944598 DOI: 10.1016/j.ajpath.2012.07.027]
36. Goldenring JR, Nam KT, Wang TC, Mills JC, Wright NA. Spasmolytic polypeptide-expressing metaplasia and intestinal metaplasia: time for reevaluation of metaplasias and the origins of gastric cancer. Gastroenterology 2010; 138: 2207-2210, 2210.e1 [PMID: 20450866 DOI: 10.1053/j.gastro.2010.04.023]
37. Jhala NC, Montemor M, Jhala D, Lu L, Talley L, Haber MM, Lechago J. Pancreatic acinar cell metaplasia in autoimmune gastritis. Arch Pathol Lab Med 2003; 127: 854-857 [PMID: 12823041]
38. Rugge M, Fassan M, Pizzi M, Pennelli G, Nitti D, Farinati F. Operative Link for Gastritis Assessment gastritis staging incorporates intestinal metaplasia subtyping. Hum Pathol 2011; 42: 1539-1544 [PMID: 21481917 DOI: 10.1016/j.humpath.2010.12.017]
39. Rugge M, Pennelli G, Pilozzi E, Fassan M, Ingravallo G, Russo VM, Di Mario F. Gastritis: the histology report. Dig Liver Dis 2011; 43 Suppl 4: S373-S384 [PMID: 21459343 DOI: 10.1016/S1590-8658(11)60593-8]
40. Rugge M, Fassan M, Graham DY. Clinical guidelines: Secondary prevention of gastric cancer. Nat Rev Gastroenterol Hepatol 2012; 9: 128-129 [PMID: 22330815 DOI: 10.1038/nrgastro.2012.19]
41. Cockburn AN, Morgan CJ, Genta RM. Neuroendocrine proliferations of the stomach: a pragmatic approach for the perplexed pathologist. Adv Anat Pathol 2013; 20: 148-157 [PMID: 23574771 DOI: 10.1097/PAP.0b013e31828d185d]
42. Basuroy R, Srirajaskanthan R, Prachalias A, Quaglia A, Ramage JK. Review article: the investigation and management of gastric neuroendocrine tumours. Aliment Pharmacol Ther 2014; 39: 1071-1084 [PMID: 24628514 DOI: 10.1111/apt.12698]
43. Syder AJ, Karam SM, Mills JC, Ippolito JE, Ansari HR, Farook V, Gordon JI. A transgenic mouse model of metastatic carcinoma involving transdifferentiation of a gastric epithelial lineage progenitor to a neuroendocrine phenotype. Proc Natl Acad Sci USA 2004; 101: 4471-4476 [PMID: 15070742]
44. Lahner E, Esposito G, Pilozzi E, Galli G, Corleto VD, Di Giulio E, Annibale B. Gastric cancer in patients with type I gastric carcinoids. Gastric Cancer 2015; 18: 564-570 [PMID: 24890255]
45. Hsing AW, Hansson LE, McLaughlin JK, Nyren O, Blot WJ, Ekbom A, Fraumeni JF. Pernicious anemia and subsequent cancer. A population-based cohort study. Cancer 1993; 71: 745-750 [PMID: 8431855]
46. Borch K, Ahrén B, Ahlman H, Falkmer S, Granérus G, Grimelius L. Gastric carcinoids: biologic behavior and prognosis after differentiated treatment in relation to type. Ann Surg 2005; 242: 64-73 [PMID: 15973103]
47. Vieth M, Montgomery EA. Some observations on pyloric gland adenoma: an uncommon and long ignored entity! J Clin Pathol 2014; 67: 883-890 [PMID: 25092673]
48. Chen ZM, Scudiere JR, Abraham SC, Montgomery E. Pyloric gland adenoma: an entity distinct from gastric foveolar type adenoma. Am J Surg Pathol 2009; 33: 186-193 [PMID: 18830123 DOI: 10.1097/PAS.0b013e31817d7ff4]
49. Arslan Pagnini C, Rugge M. Gastric cancer: problems in histological diagnosis. Histopathology 1982; 6: 391-398 [PMID: 7118079]
50. Rugge M, Correa P, Dixon MF, Hattori T, Leandro G, Lewin K, Riddell RH, Sipponen P, Watanabe H. Gastric dysplasia: the Padova international classification. Am J Surg Pathol 2000; 24: 167-176 [PMID: 10680883]
51. Nguyen TL, Khurana SS, Bellone CJ, Capoccia BJ, Sagartz JE, Kesman RA, Mills JC, DiPaolo RJ. Autoimmune gastritis mediated by CD4+ T cells promotes the development of gastric cancer. Cancer Res 2013; 73: 2117-2126 [PMID: 23378345 DOI: 10.1158/0008-5472.CAN-12-3957]
52. Norcross JW, Monroe SE, Griffin BG. The development of gastric carcinoma in pernicious anemia. Ann Intern Med 1952; 37: 338-343 [PMID: 14944114]
53. Vannella L, Lahner E, Osborn J, Bordi C, Miglione M, Delle Fave G, Annibale B. Risk factors for progression to gastric neoplastic lesions in patients with atrophic gastritis. Aliment Pharmacol Ther 2010; 31: 1042-1050 [PMID: 20175768 DOI: 10.1111/j.1365-2036.2010.04268.x]
54. Dixon MF, Genta RM, Yardley JH, Correa P. Classification and grading of gastritis. The updated Sydney System. International Workshop on the Histopathology of Gastritis, Houston 1994. Am J Surg Pathol 1996; 20: 1161-1181 [PMID: 8827022]
55. Price AB. The Sydney System: histological division. J Gastroenterol Hepatol 1991; 6: 209-222 [PMID: 1912431]
56. Morson BC, Sobin LH, Grundmann E, Johansen A, Nagayo T, Serck-Hanssen A. Precancerous conditions and epithelial dysplasia in the stomach. J Clin Pathol 1980; 33: 711-721 [PMID: 7430384]
57. Hirota WK, Zuckerman MJ, Adler DG, Davila RE, Egan J, Leighton JA, Qureshi WA, Rajan E, Fanelli R, Wheeler-Harbaugh J, Baron TH, Faigel DO. ASGE guideline: the role of endoscopy in the surveillance of premalignant conditions of the upper GI tract. Gastrointest Endosc 2006; 63: 570-580 [PMID: 16564854]
58. Dinis-Ribeiro M, Areia M, de Vries AC, Marcos-Pinto R, Monteiro-Soares M, O'Connor A, Pereira C, Pimentel-Nunes P, Correia R, Ensari A, Dumonceau JM, Machado JC, Macedo G, Malfertheiner P, Matysiak-Budnik T, Megraud F, Miki K, O' Morain C, Peek RM, Ponchon T, Ristimaki A, Rembacken B, Carneiro F, Kuipers EJ. Management of precancerous conditions and lesions in the stomach (MAPS): guideline from the European Society of Gastrointestinal Endoscopy (ESGE), European Helicobacter Study Group (EHSG), European Society of Pathology (ESP), and the Sociedade Portuguesa de Endoscopia Digestiva (SPED). Virchows Arch 2012; 460: 19-46 [PMID: 22190006 DOI: 10.1007/s00428-011-1177-8]
59. Rugge M, Capelle LG, Cappellesso R, Nitti D, Kuipers EJ. Precancerous lesions in the stomach: from biology to clinical patient management. Best Pract Res Clin Gastroenterol 2013; 27: 205-223 [PMID: 23809241 DOI: 10.1016/j.bpg.2012.12.007]
60. Rugge M, Capelle LG, Fassan M. Individual risk stratification of gastric cancer: evolving concepts and their impact on clinical practice. Best Pract Res Clin Gastroenterol 2014; 28: 1043-1053 [PMID: 25439070 DOI: 10.1016/j.bpg.2014.09.002]